FDA Investigator Samir C Gala
Samir C Gala has conducted inspections on 24 sites in 5 countries as of 31 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
31 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Netherlands,
India,
Germany,
Spain
FDA Investigators that have inspected at least one site in common with Samir C Gala:
Addam S Reynolds,
Adetutu M Gidado,
Alan P Kurtzberg,
Alberto A Viciedo,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Annemarie B Randow,
Annemarie Bodnar,
Anthony C Warchut,
Ariel Cruz Figueroa,
Armen H Youssoufian,
Atul J Agrawal,
Brandy N Lepage,
Brenna L Macdowell,
Cassandra L Abellard,
Cheryl A Clausen,
Chhaya S Shetty,
Christian F Gomez Lugo,
Christopher Janik,
Daniel J Grabicki,
Daniel J Roberts,
Daniel L Zheng,
Dawn L Wydner,
Diane C Thibodeau,
Diane M Prince,
Dien N Nguyen,
Dominic R Frasca,
Douglas C Kovacs,
Edmund F Mrak, Jr,
Emily J Schramm,
Evan Tong,
Frederick F Razzaghi,
Gam S Zamil,
Guerlain Ulysse,
Helen Verdel,
James R Birkenstamm,
Janet A Rajan,
Janete F Guardia,
Jay B Shah,
Jeffrey J Thibodeau,
Jenny Sung,
Jessica S Estriplet,
Jill M Sooter,
Jill Mielziner,
Jogy George,
John P Mistler,
Jonah S Ufferfilge,
Jonathan S Helfgott,
Jose M Cayuela,
Josh Renzo N Ramilo,
Joy Rkozlowski Klena,
Justine Tomasso,
Karen E D'orazio,
Karishma G Gopaul,
Kelli F Dobilas,
Kenneth H Williams,
Kristy A Zielny,
Larry Johnson,
Lauren L Vajo,
Lawrence R Johnson,
LCDR Debra Emerson,
Li Li,
Loretta Nemchik,
Mark R Mcclain,
Maya M Davis,
Meisha A Mandal,
Melissa T Roy,
Meyer J Slobotsky,
Michael A Charles,
Michael G Mayfield,
Michael R Klapal,
Michael Serrano,
Mindy M Chou,
Nancy F Scheraga,
Nealie C Newberger,
Nerizza B Guerin,
Nicholas A Violand,
Nicole E Knowlton,
Niketa Patel,
Paige R Mccoy,
Patrick C Klotzbuecher,
Paul L Bellamy,
Puspa Suresh Jayasekara,
Rachael A Moliver,
Rebecca B Welch,
Regina T Brown,
Robert J Martin,
Roger F Zabinski,
Rose Ljean Mary,
Ruben C Quintana,
Russell J Glapion,
Satheesh K Podaralla,
Sean R Marcsisin,
Stephen J Mottola,
Stephenie M Ortiz,
Steve Y Rhieu, PhD,
Suchan Kim,
Unnee Ranjan,
Victoria Spivak,
Yong Wang,
Yumi J Hiramine,
Yvesna C Blaise,
Zhongren Wu
Samir C Gala's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2021 | FDA 483 | Brand-Nu Laboratories, LLC - Form 483, 2021-11-22 |
July, 2021 | FDA 483 | PETNET SOLUTIONS, INC. - Form 483, 2021-07-28 |
October, 2022 | FDA 483 | Unipharm, Inc - Form 483, 2022-10-05 |
June, 2022 | FDA 483 | Hikma Injectables USA Inc. - Form 483, 2022-06-08 |
August, 2022 | FDA 483 | RK PHARMA INC - Form 483, 2022-08-12 |
March, 2020 | FDA 483 Response | Edge Pharma, LLC - Form 483R, 2020-05-01 |
March, 2021 | EIR | PINE LAKE INVESTMENTS, INC. - EIR, 2021-03-18 |
April, 2022 | FDA 483 | American Distilling Inc. - Form 483, 2022-04-26 |
January, 2023 | FDA 483 | Miyoshi America, Inc. - Form 483, 2023-01-13 |
March, 2020 | FDA 483 | Edge Pharma, LLC - Form 483, 2020-03-30 |
March, 2022 | FDA 483 | Centrix Inc - Form 483, 2022-03-02 |
May, 2021 | FDA 483 | Miyoshi America, Inc. - Form 483, 2021-05-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more